352 results on '"Fujimura, Yoshihiro"'
Search Results
2. Patent ductus arteriosus generates neonatal hemolytic jaundice with thrombocytopenia in Upshaw-Schulman syndrome
3. Blood group antigen A on von Willebrand factor is more protective against ADAMTS13 cleavage than antigens B and H
4. Recombinant ADAMTS-13: first-in-human pharmacokinetics and safety in congenital thrombotic thrombocytopenic purpura
5. Mutations and Common Polymorphisms in ADAMTS13 Gene Responsible for von Willebrand Factor-Cleaving Protease Activity
6. Correction: Antibody recognition of complement factor H reveals a flexible loop involved in atypical hemolytic uremic syndrome pathogenesis
7. Antibody recognition of complement factor H reveals a flexible loop involved in atypical hemolytic uremic syndrome pathogenesis
8. UV light-emitting diode (UV-LED) at 265 nm as a potential light source for disinfecting human platelet concentrates
9. Involvement of the ADAMTS13-VWF axis in acute Kawasaki disease and effects of intravenous immunoglobulin
10. Familial C3 glomerulonephritis associated with mutations in the gene for complement factor B
11. Two Mechanistic Pathways for Thienopyridine-Associated Thrombotic Thrombocytopenic Purpura: A Report From the SERF-TTP Research Group and the RADAR Project
12. ADAMTS13活性の迅速測定法の導入により、血小板輸血を施行された特発性血栓性血小板減少性紫斑病患者の30日生存率が向上した
13. Profiles of Coagulation and Fibrinolysis Activation-Associated Molecular Markers of Atypical Hemolytic Uremic Syndrome in the Acute Phase
14. Successful Treatment of Primitive Neuroectodermal Tumor-associated Microangiopathy with Multiple Bone Metastases
15. Novel compound heterozygote mutations (H234Q/R1206X) of the ADAMTS13 gene in an adult patient with Upshaw–Schulman syndrome showing predominant episodes of repeated acute renal failure
16. Plasma ADAMTS13 activity may predict early adverse events in living donor liver transplantation: Observations in 3 cases
17. Molecular characterization of ADAMTS13 gene mutations in Japanese patients with Upshaw-Schulman syndrome
18. Primary structure of two-chain botrocetin, a von Willebrand factor modulatorpurified from the venom of Bothrops jararaca
19. Clinical guides for atypical hemolytic uremic syndrome in Japan
20. Mural thrombus generation in type 2A and 2B von Willebrand disease under flow conditions
21. Poor responder to plasma exchange therapy in acquired thrombotic thrombocytopenic purpura is associated with ADAMTS13 inhibitor boosting: visualization of an ADAMTS13 inhibitor complex and its proteolytic clearance from plasma
22. Increased Plasma Levels of Adrenomedullin in Patients with Systemic Inflammatory Response Syndrome
23. The International Hereditary Thrombotic Thrombocytopenic Purpura Registry: key findings at enrollment until 2017
24. Genotype-Phenotype Correlation in Congenital TTP: New Insights from a Multicentre Study with 121 Patients
25. Low Shear Stress Can Initiate von Willebrand Factor-dependent Platelet Aggregation in Patients with Type IIB and Platelet-type von Willebrand Disease
26. Candidate gene analysis using genomic quantitative PCR: identification of ADAMTS13 large deletions in two patients with Upshaw-Schulman syndrome
27. ADAMTS13 unbound to larger von Willebrand factor multimers in cryosupernatant: Implications for selection of plasma preparations for TTP treatment
28. Intravitreal injection of aflibercept, an anti-VEGF antagonist, down-regulates plasma von Willebrand factor in patients with age-related macular degeneration
29. Severe reduction of free-form ADAMTS13, unbound to von Willebrand factor, in plasma of patients with HELLP syndrome
30. ABO Blood Group Antigens on Human Plasma von Willebrand Factor After ABO-Mismatched Bone Marrow Transplantation
31. The cDNA cloning of human placental ecto-ATP diphosphohydrolases I and II
32. Ratio of von Willebrand factor propeptide to ADAMTS13 is associated with severity of sepsis
33. Reduced larger von Willebrand factor multimers at dawn in OSA plasmas reflect severity of apnoeic episodes
34. ADAMTS13 activity may predict the cumulative survival of patients with liver cirrhosis in comparison with the Child-Turcotte-Pugh score and the Model for End-Stage Liver Disease score
35. Decreased activity of plasma ADAMTS13 are related to enhanced cytokinemia and endotoxemia in patients with acute liver failure
36. Correction: A Novel Quantitative Hemolytic Assay Coupled with Restriction Fragment Length Polymorphisms Analysis Enabled Early Diagnosis of Atypical Hemolytic Uremic Syndrome and Identified Unique Predisposing Mutations in Japan
37. Severe Reduction of Free ADAMTS13, Unbound to Von Willebrand Factor, in Plasma Milieu Is a Unique Feature of HELLP Syndrome
38. Quantitative ELISA Using N10 Antibody, Targeting on VWF-Y1605 Residue, Indicates That N-Linked Blood Group Type A Carbohydrate on VWF Molecule Functions Against ADAMTS13 Cleavage
39. Quantification of the Actual Numbers of Transplantable CD34+CD133+ Hematopoietic Stem Cells Residing in the Umbilical Cord Blood (UCB) Units: A New Indicator of Quality Assurance of UCB Units
40. A first bout of thrombotic thrombocytopenic purpura triggered by herpes simplex infection in a 45-year-old nulliparous female with Upshaw-Schulman syndrome
41. Rapid Restoration of Thrombus Formation and High-Molecular-Weight von Willebrand Factor Multimers in Patients with Severe Aortic Stenosis After Valve Replacement
42. Investigator-Initiated Phase 2 Trial of Rituximab in Adult Japanese Patients with Treatment-Resistant Acquired Thrombotic Thrombocytopenic Purpura
43. von Willebrand Factor-Rich Platelet Thrombi in the Liver Cause Sinusoidal Obstruction Syndrome following Oxaliplatin-Based Chemotherapy
44. A note on the carrier detection of hemophilia a
45. Determination of ADAMTS13 and Its Clinical Significance for ADAMTS13 Supplementation Therapy to Improve the Survival of Patients with Decompensated Liver Cirrhosis
46. A Novel Quantitative Hemolytic Assay Coupled with Restriction Fragment Length Polymorphisms Analysis Enabled Early Diagnosis of Atypical Hemolytic Uremic Syndrome and Identified Unique Predisposing Mutations in Japan
47. STEC:O111‐HUS complicated by acute encephalopathy in a young girl was successfully treated with a set of hemodiafiltration, steroid pulse, and soluble thrombomodulin under plasma exchange
48. A Unique Case Involving a Female Patient with Upshaw-Schulman Syndrome: Low Titers of Antibodies against ADAMTS13 prior to Pregnancy Disappeared after Successful Delivery
49. Introduction of a Quick Assay for ADAMTS13 Activity Improved a Survival of Acquired TTP Patients Who Received Platelet Transfusions
50. Decreased Platelet Thrombus Size, Due to a Heightened Proteolysis of VWF By ADAMTS13, Is Quickly Restored after Valve Replacement in Aortic Stenosis Patients
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.